Teva ADR earnings, Revenue beat in Q1

  • Investing.com
Teva ADR earnings, Revenue beat in Q1

Investing.com - Teva ADR reported on Thursday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.

Teva ADR announced earnings per share of $0.76 on revenue of $4.36B. Analysts polled by Investing.com anticipated EPS of $0.59 on revenue of $4.15B. That with comparison to EPS of $0.6 on revenue of $4.3B in the same period a year before.Teva ADR had reported EPS of $0.62 on revenue of $4.47B in the previous quarter.Analysts are expecting EPS of $0.58 and revenue of $4.06B in the upcoming quarter.

Teva ADR shares are up 6.94% from the beginning of the year and are trading at $10.48 , down-from-52-week-high.They are outperforming the EUR/USD which is down 0% year to date.

Teva ADR follows other major Healthcare sector earnings this month

Teva ADR's report follows an earnings beat by J&J on Tuesday, April 14, 2020, who reported EPS of $2.3 on revenue of $20.69B, compared to forecasts EPS of $2.02 on revenue of $19.73B.

Novartis ADR had beat expectations on Tuesday, April 28, 2020 with first quarter EPS of $1.56 on revenue of $12.28B, compared to forecast for EPS of $1.39 on revenue of $12B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles